Dave Vivek P, Pappuru Rajeev R, Khader Mohammad A, Basu Sayan, Tyagi Mudit, Pathengay Avinash
Smt. Kanuri Santhamma Center for Vitreoretinal Services, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Smt. Kanuri Santhamma Center for Vitreoretinal Services; Academy for Eye Care Education, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Indian J Ophthalmol. 2020 Aug;68(8):1587-1592. doi: 10.4103/ijo.IJO_1840_19.
To describe the outcomes of endophthalmitis with opaque cornea managed with primary endoscopic vitrectomy and secondary keratoplasty.
Retrospective consecutive interventional case series. All cases of endophthalmitis with opaque cornea which underwent endoscopic vitrectomy followed by secondary keratoplasty were analyzed. The study period was from Jan 2015 to March 2019. The outcome measures were resolution of infection, the magnitude of unnecessary keratoplasties avoided and corneal graft survival. The final anatomic and functional outcomes were reported and compared with relevant literature.
Seventy-eight eyes of 78 patients underwent endoscopic pars plana vitrectomy for endophthalmitis with the opaque cornea, of these 14 eyes of 14 patients were deemed eligible for further corneal intervention and were included in the study. The mean age at presentation was 42.27 ± 21.6 years (median 36 years). Etiology-wise, eight cases (57.14%) were post-trauma, three cases (21.42%) post-keratoplasty, two cases (14.28%) were endogenous, and one case (7.14%) following corneal dermoid excision and wound melt. Culture positivity was in 5/14 (35.71%). The mean interval between endoscopic vitrectomy and keratoplasty was 5.42 ± 2.69 months (median 3.5 months). The mean follow-up noted was 20.42 ± 11.45 months (median 17.5 months). The infection resolved in 100% of cases. Unnecessary keratoplasties were avoided in 64/78 (82%) cases due to the primary endoscopic intervention. The favorable anatomic outcome was seen in 11/14 (78.57%) of cases and favorable functional outcome in 8/14 (57.14%) cases.
Endoscopic vitrectomy allows for early intervention in endophthalmitis with the opaque cornea. This facilitates early settlement of infection, globe preservation, greater graft survival, and lesser repeat posterior segment procedures.
描述采用原发性内镜玻璃体切除术和二期角膜移植术治疗角膜混浊性眼内炎的结果。
回顾性连续介入病例系列。分析所有接受内镜玻璃体切除术并随后进行二期角膜移植术的角膜混浊性眼内炎病例。研究期间为2015年1月至2019年3月。观察指标为感染的消退情况、避免不必要角膜移植术的程度以及角膜移植片的存活情况。报告最终的解剖和功能结果,并与相关文献进行比较。
78例患者的78只眼因角膜混浊性眼内炎接受了内镜下经睫状体平坦部玻璃体切除术,其中14例患者的14只眼被认为适合进一步的角膜干预并纳入研究。就诊时的平均年龄为42.27±21.6岁(中位数36岁)。病因方面,8例(57.14%)为外伤后,3例(21.42%)为角膜移植术后,2例(14.28%)为内源性,1例(7.14%)为角膜皮样瘤切除和伤口融解后。培养阳性率为5/14(35.71%)。内镜玻璃体切除术与角膜移植术之间的平均间隔时间为5.42±2.69个月(中位数3.5个月)。观察到的平均随访时间为20.42±11.45个月(中位数17.5个月)。100%的病例感染得到消退。由于原发性内镜干预,64/78(82%)的病例避免了不必要的角膜移植术。11/14(78.57%)的病例获得了良好的解剖结果,8/14(57.14%)的病例获得了良好的功能结果。
内镜玻璃体切除术可对角膜混浊性眼内炎进行早期干预。这有助于感染的早期消退、眼球保留、更高的移植片存活率以及更少的重复后段手术。